India’s ₹3 trillion Production-Linked Incentive scheme has driven ₹2.2 trillion in capital spending by March 2026. While mobile and pharma sectors lead in output, overall incentive payouts are trailing at 21%. Investors should monitor how these investments translate into long-term profit margins as domestic supply chains develop.
Four years into the Production-Linked Incentive (PLI) scheme, the Indian manufacturing landscape shows a clear divide between fast-growing segments and those still in the foundational phase. As of March 2026, industry data indicates that approximately 55-60% of the planned ₹4 trillion capital spending has been completed. This move has generated incremental sales worth ₹20.4 trillion, with exports accounting for nearly ₹8.3 trillion of that output.
Incentive Payouts and Performance Gaps
While capital investment remains strong, the actual disbursement of government incentives is moving at a different speed. Data shows that by the end of FY2027, only about 21% of the total ₹3 trillion allocated budget had been paid out or approved for disbursement. This gap is largely due to the structure of the scheme, which ties payouts strictly to future incremental sales and production milestones. For investors, this means the financial benefits from these incentives are deferred, and the positive impact on company cash flows will become clearer only as production scales up over the coming years.
Sectoral Leaders and Lagging Segments
The mobile phone and pharmaceutical sectors have emerged as the strongest performers. The mobile manufacturing sector saw a production increase of nearly 195% between FY2021 and FY2026, with about half of its allocated incentive funds expected to be used by next year. Meanwhile, the pharmaceutical industry has exceeded its initial investment targets, reaching cumulative investments of ₹427 billion by December 2025. This has been instrumental in increasing the local production of essential bulk drugs and specialty medicines.
Conversely, sectors such as semiconductors, Advanced Chemistry Cell (ACC) batteries, and solar PV modules are still in the early stages. While these areas have attracted significant investment pledges—including ₹1.64 trillion for semiconductors—the bulk of commercial production is not expected to commence until FY2027 or later. Investors should be aware that these sectors carry a higher risk of execution delays as they rely heavily on setting up complex, new industrial ecosystems.
Investor Monitorables Beyond Incentives
The success of companies participating in these programs will depend less on the incentives themselves and more on their ability to build efficient domestic supply chains. The current data highlights that financial support is only a starting point. Moving forward, the most important factor for investors will be whether companies can achieve the necessary scale and cost competitiveness to survive once the incentive periods end. Keeping track of the commissioning timelines for semiconductor and battery projects, alongside the actual sales growth in the automotive and textile segments, will be essential for assessing the long-term value of these government-backed manufacturing initiatives.